Researcher profile

David Golan

David Golan contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
6topics
3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2014arXiv

Effective Genetic Risk Prediction Using Mixed Models

To date, efforts to produce high-quality polygenic risk scores from genome-wide studies of common disease have focused on estimating and aggregating the effects of multiple SNPs. Here we propose a novel statistical approach for genetic risk prediction, based on random and mixed effects models. Our approach (termed GeRSI) circumvents the need to estimate the effect sizes of numerous SNPs by treating these effects as random, producing predictions which are consistently superior to current state of the art, as we demonstrate in extensive simulation. When applying GeRSI to seven phenotypes from the WTCCC study, we confirm that the use of random effects is most beneficial for diseases that are known to be highly polygenic: hypertension (HT) and bipolar disorder (BD). For HT, there are no significant associations in the WTCCC data. The best existing model yields an AUC of 54%, while GeRSI improves it to 59%. For BD, using GeRSI improves the AUC from 55% to 62%. For individuals ranked at the top 10% of BD risk predictions, using GeRSI substantially increases the BD relative risk from 1.4 to 2.5.

preprint2013arXiv

A method for generating realistic correlation matrices

Simulating sample correlation matrices is important in many areas of statistics. Approaches such as generating Gaussian data and finding their sample correlation matrix or generating random uniform $[-1,1]$ deviates as pairwise correlations both have drawbacks. We develop an algorithm for adding noise, in a highly controlled manner, to general correlation matrices. In many instances, our method yields results which are superior to those obtained by simply simulating Gaussian data. Moreover, we demonstrate how our general algorithm can be tailored to a number of different correlation models. Using our results with a few different applications, we show that simulating correlation matrices can help assess statistical methodology.

preprint2013arXiv

Narrowing the gap on heritability of common disease by direct estimation in case-control GWAS

One of the major developments in recent years in the search for missing heritability of human phenotypes is the adoption of linear mixed-effects models (LMMs) to estimate heritability due to genetic variants which are not significantly associated with the phenotype. A variant of the LMM approach has been adapted to case-control studies and applied to many major diseases by Lee et al. (2011), successfully accounting for a considerable portion of the missing heritability. For example, for Crohn's disease their estimated heritability was 22% compared to 50-60% from family studies. In this letter we propose to estimate heritability of disease directly by regression of phenotype similarities on genotype correlations, corrected to account for ascertainment. We refer to this method as genetic correlation regression (GCR). Using GCR we estimate the heritability of Crohn's disease at 34% using the same data. We demonstrate through extensive simulation that our method yields unbiased heritability estimates, which are consistently higher than LMM estimates. Moreover, we develop a heuristic correction to LMM estimates, which can be applied to published LMM results. Applying our heuristic correction increases the estimated heritability of multiple sclerosis from 30% to 52.6%.